🧫
experiment

GPR37 deficiency in oligodendrocytes prevented neurodegeneration in multiple PD models, reducing neuroinflammation, dopamine neuron degeneration, and behavioral deficits.

🧫 Experiment Protocol Animal ModelParkinson's diseaseGPR37mus_musculusextracted
Genetic manipulation using GPR37-deficient oligodendrocytes tested across multiple PD animal models
PRIMARY OUTCOME
GPR37 deficiency in oligodendrocytes prevented neurodegeneration in multiple PD models, reducing neuroinflammation, dopamine neuron degeneration, and behavioral deficits.
LINKED HYPOTHESES
Source: pmid_39913287
🧫 Experiment Extras
PATHWAY
prosaposin-GPR37-IL-6 axis
MARKET PRICE
$0.50
STATUS
extracted
Related Target
GPR37composite 0.566
View on SciDEX ↗